BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7063488)

  • 1. Hypersensitivity to warfarin in rats with Walker 256 carcinoma.
    Owen CA
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):1-3. PubMed ID: 7063488
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Walker 256 tumor or turpentine on hemostatic factors locally and generally in rats.
    Owen CA
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):919-24. PubMed ID: 7198980
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin therapy. 1.
    Deykin D
    N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rodenticide effect of warfarin. 1. Effect on blood coagulation].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 May; 24(5):802-6. PubMed ID: 4408104
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

  • 6. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):806-10. PubMed ID: 5023769
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT.
    PYOERAELAE K
    Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.
    Silberman S; Fareed J; Walenga J
    Br J Exp Pathol; 1986 Aug; 67(4):597-604. PubMed ID: 3091059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin therapy. 2.
    Deykin D
    N Engl J Med; 1970 Oct; 283(15):801-3. PubMed ID: 4917271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the interaction of warfarin and clofibrate in man.
    O'Reilly RA; Sahud MA; Robinson AJ
    Thromb Diath Haemorrh; 1972 Apr; 27(2):309-18. PubMed ID: 4340370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Notes on coagulation in the neonatal period. II. Effect of vitamin K on the activity of coagulation factors II, VII and X].
    Duvina PL; Simoni MR; Pieroni O; Guazzini S
    Minerva Pediatr; 1978 Apr; 30(8):639-44. PubMed ID: 661772
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
    Bell RG; Matschiner JT
    Nature; 1972 May; 237(5349):32-3. PubMed ID: 4555434
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental warfarin poisoning in the dog. Platelet function, coagulation and fibrinolysis.
    Forbes CD; Thomson C; Prentice CR; McNicol GP; McEwan AD
    J Comp Pathol; 1973 Apr; 83(2):173-80. PubMed ID: 4761660
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a humoral agent capable of raising vitamin-K-dependent coagulation factors in rabbits.
    Karpatkin M; Karpatkin S
    Br J Haematol; 1973 May; 24(5):553-62. PubMed ID: 4712828
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex difference in the clotting factor response to warfarin and in the rate of warfarin metabolism in the rat.
    Pyörälä K
    Ann Med Exp Biol Fenn; 1968; 46(1):23-34. PubMed ID: 5727659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.